BiotechTube

Ciprofloxacin

ApprovedCompleted
0 watching 0 views this week📈 Rising
77
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
✓
Phase 3
5
Approved
Indication / Disease

UTI - Lower Urinary Tract Infection

Conditions

UTI - Lower Urinary Tract Infection, Antibiotic Resistant Infection

Trial Timeline

Dec 15, 2017 → Oct 26, 2018

NCT ID
NCT03366207

About Ciprofloxacin

Ciprofloxacin is a approved stage product being developed by Iterum Therapeutics for UTI - Lower Urinary Tract Infection. The current trial status is completed. This product is registered under clinical trial identifier NCT03366207. Target conditions include UTI - Lower Urinary Tract Infection, Antibiotic Resistant Infection.

Hype Score Breakdown

Clinical
30
Activity
20
Company
2
Novelty
10
Community
12

Clinical Trials (1)

NCT IDPhaseStatus
NCT03366207ApprovedCompleted

Competing Products

20 competing products in UTI - Lower Urinary Tract Infection

See all competitors
ProductCompanyStageHype Score
JSP191Jasper TherapeuticsPhase 1
25
solifenacin succinate + tamsulosin hydrochloride + Placebo to solifenacin + Placebo to tamsulosinAstellas PharmaPhase 2
52
SolifenacinAstellas PharmaPre-clinical
23
Tamsulosin + SolifenacinAstellas PharmaApproved
85
Vesitirim™ (Solifenacin)Astellas PharmaPre-clinical
23
Mirabegron + PlaceboAstellas PharmaPhase 2
52
tamsulosin hydrochloride/solifenacin succinate fixed dose combination (0.4 mg/6 mg) + tamsulosin hydrochloride/solifenacin succinate fixed dose combination (0.4 mg/9 mg)Astellas PharmaPhase 3
77
tamsulosin hydrochloride + solifenacin succinate + PlaceboAstellas PharmaPhase 2
52
Tamsulosin + SolifenacinAstellas PharmaApproved
85
Tamsulosin OCASAstellas PharmaApproved
85
DuloxetineShionogiPhase 3
77
Duloxetine + PlaceboShionogiPhase 3
77
AZD1656AstraZenecaPhase 1
33
Nirsevimab + PlaceboAstraZenecaPhase 3
77
RSVpreF + PlaceboPfizerPhase 3
76
GabapentinPfizerApproved
84
Erythropoiesis-stimulating agents (ESAs) + Luspatercept + Lenalidomide + Hypomethylating agents (HMAs) + Reb blood cell transfusionBristol Myers SquibbPre-clinical
22
ALX-0171 1.5 mg/kgSanofiPhase 2
51
ALX-0171 3.0 mg/kg + ALX-0171 6.0 mg/kg + ALX-0171 9.0 mg/kgSanofiPhase 2
51
ALX-0171 Dose 1 + ALX-0171 Dose 2 + PlaceboSanofiPhase 2
51

Other Products from Iterum Therapeutics

Sulopenem etzadroxil/probenecid + Amoxicillin/clavulanatePhase 3
69
Sulopenem-Etzadroxil/Probenecid + CiprofloxacinPhase 3
69
Sulopenem + Sulopenem-Etzadroxil/Probenecid + Ertapenem + Ciprofloxacin + Amoxicillin-clavulanatePhase 3
69
Ertapenem + Sulopenem-Etzadroxil/Probenecid + Ciprofloxacin + Metronidazole + Amoxicillin-Clavulanate + SulopenemPhase 3
69
Azithromycin plus hydroxychloroquinePhase 3
69